Kwame Osei Endocrine Update 2024
Saturday, February 24, 2024
7:30 a.m. - 5:30 p.m.
Nationwide Hotel and Conference Center, Columbus Ohio
Register - In Person Register - Virtual
The Endocrine Update was created in 1999 with a singular mission: to educate clinical providers who take care of patients with endocrine disorders. The conference covers epidemiology, pathophysiology, diagnosis and treatment of common endocrines.
Course Objectives:
At the conclusion of this activity, learners should be able to:
1. Describe strategies for Advancing Equity in Diabetes Management
2. Explain the Cardiovascular-Kidney-Metabolic Syndrome and how it relates to Endocrinology
3. Describe the use of GLP1 and GLP1/GIP agonists for weight management
4. Describe the use of GLP1 and GLP1/GIP agonists for management and prevention of CVD
5. Describe the use of GLP1 and GLP1/GIP agonists to slow progression of diabetic kidney disease
6. Discuss multiple options for CGM and for AID systems
7. Describe the immune therapy related endocronopathies
8. Explain how to apply the clinical practice guidelines for adrenal incidentalomas
9. Explain how to apply the 2024 clinical practice guidelines for thyroid cancer
10. Explain how to differentiate and apply the clinical practice guidelines for osteoporosis
11. Discuss current evaluation and treatment options for male hypogonadism
12. Identify pituitary and adrenal disorders during pregnancy
13. Explain why NAFLD is now called MASLD
AMA credit designation statement
The Ohio State University Center for Continuing Medical Education (CCME) designates this live activity for a maximum of 9 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.